Search Results | Clinicalinfo

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2621 – 2640 of 3236

https://clinicalinfo.hiv.gov/node/9425

Mycobacterium tuberculosis

https://clinicalinfo.hiv.gov/node/9426

Lamivudine (Epivir, 3TC)

https://clinicalinfo.hiv.gov/node/9427

Appendix A, Table 1. Antiretrovirals Available in Fixed-Dose Combination Tablets or as a Co-packaged Formulation, by Drug Class

https://clinicalinfo.hiv.gov/node/9428

Human Herpesvirus-8 Disease

https://clinicalinfo.hiv.gov/node/9430

Table 6. Dosing Recommendations for Drugs Used to Treat or Prevent Opportunistic Infections that Require Dosage Adjustment in Adults With Renal Insufficiency

https://clinicalinfo.hiv.gov/node/9432

Table 1. Primary Prophylaxis

https://clinicalinfo.hiv.gov/node/9434

https://clinicalinfo.hiv.gov/node/9436

Mycobacterium tuberculosis Infection and Disease

https://clinicalinfo.hiv.gov/node/9437

https://clinicalinfo.hiv.gov/node/9439

Special Populations: Adolescents and Young Adults With HIV

https://clinicalinfo.hiv.gov/node/9440

Table 3. Treatment

https://clinicalinfo.hiv.gov/node/9442

Antiretroviral Treatment Interruption in Children With HIV

https://clinicalinfo.hiv.gov/node/9443

https://clinicalinfo.hiv.gov/node/9444

https://clinicalinfo.hiv.gov/node/9445

Initiation of Antiretroviral Therapy

https://clinicalinfo.hiv.gov/node/9446

Herpes Simplex Virus

https://clinicalinfo.hiv.gov/node/9447

https://clinicalinfo.hiv.gov/node/9448

https://clinicalinfo.hiv.gov/node/9449

https://clinicalinfo.hiv.gov/node/9451